Welcome to LookChem.com Sign In|Join Free
  • or
4-(4-chloro-phenyl)-1-phenyl-1,3-dihydro-imidazole-2-thione is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

201049-99-2

Post Buying Request

201049-99-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

201049-99-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 201049-99-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,1,0,4 and 9 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 201049-99:
(8*2)+(7*0)+(6*1)+(5*0)+(4*4)+(3*9)+(2*9)+(1*9)=92
92 % 10 = 2
So 201049-99-2 is a valid CAS Registry Number.

201049-99-2Downstream Products

201049-99-2Relevant academic research and scientific papers

On the reaction of 2-phenylaminothiazoline with α-halogenoketones

Demchenko,Chumakov,Krasovskii,Pirozhenko,Lozinskii

, p. 724 - 727 (1997)

It was established that the alkylation of 2-phenylaminothiazoline with substituted phenacyl bromides proceeds at the exocyclic nitrogen atom with the formation of 5-aryl-7-phenyl-2,3-dihydroimidazo[2,1-b]thiazolium bromides. In order to confirm the struct

Synthesis, antibacterial activity and binding mode analysis of some novel 1,4-diaryl imidazole thiones

Ganguly, Swastika,Singh, Nalini,Upadhyay, Arpita

, p. 419 - 424 (2019/01/21)

A novel series of fifteen diaryl imidazole thiones 2a-o was synthesized by reacting the corresponding 1-(aryl)-2-(arylamino)-ethanones 1 with ammonium thiocyanate. The compounds have been characterized on the basis of elemental analysis and spectral data.

T-CELL INHIBITING COMPOUNDS AND THEIR USE FOR THE TREATMENT OF T-CELL-MEDIATED DISEASES

-

Page/Page column 30; 31, (2008/12/07)

The present invention relates to compounds of formula IA or IB. The present invention also concerned to a method of treating immunologic diseases or pathological conditions in association with T cell involving an immunologic component using T-cell inhibitors, optionally in combination with one or more other drugs selected from steroids, DMARDs, NSAIDs, immunosuppressive, and biological modifiers, pharmaceutical compositions comprising said compounds of formula IA or IB together with said other drugs, and the use of T-cell inhibitors for the manufacture of a pharmaceutical composition for the treatment of immunologic diseases or pathological conditions involving an immunologic component.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 201049-99-2